DBP B — Double Bond Pharmaceutical International AB (publ) Share Price
- SEK46.93m
- SEK45.45m
- SEK1.37m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 7.29 | ||
Price to Tang. Book | 7.49 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 31.82 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -180.39% | ||
Return on Equity | -200.07% | ||
Operating Margin | -787.75% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | SEKm | 0.24 | 1.16 | 0.96 | 1.24 | 1.37 | n/a | n/a | 135.07% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Double Bond Pharmaceutical International AB is a manufacturer of pharmaceutical preparation. The company is located in Uppsala, Sweden. It develops medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- November 21st, 2014
- Public Since
- July 10th, 2015
- No. of Employees
- 10
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
AktieTorget Stock Exchange
- Shares in Issue
- 102,028,223
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- Virdings Alle 32 B, UPPSALA, 75450
- Web
- https://www.doublebp.com/
- Phone
- Auditors
- Grant Thornton Sweden AB
Upcoming Events for DBP B
Similar to DBP B
Abera Bioscience AB
AktieTorget Stock Exchange
Aptahem AB
AktieTorget Stock Exchange
Arcede Pharma AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
FAQ
As of Today at 20:19 UTC, shares in Double Bond Pharmaceutical International AB (publ) are trading at SEK0.47. This share price information is delayed by 15 minutes.
Shares in Double Bond Pharmaceutical International AB (publ) last closed at SEK0.47 and the price had moved by +15.96% over the past 365 days. In terms of relative price strength the Double Bond Pharmaceutical International AB (publ) share price has outperformed the FTSE Global All Cap Index by +1.98% over the past year.
There is no consensus recommendation for this security.
Double Bond Pharmaceutical International AB (publ) does not currently pay a dividend.
Double Bond Pharmaceutical International AB (publ) does not currently pay a dividend.
Double Bond Pharmaceutical International AB (publ) does not currently pay a dividend.
To buy shares in Double Bond Pharmaceutical International AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK0.47, shares in Double Bond Pharmaceutical International AB (publ) had a market capitalisation of SEK47.44m.
Here are the trading details for Double Bond Pharmaceutical International AB (publ):
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: DBP B
Based on an overall assessment of its quality, value and momentum Double Bond Pharmaceutical International AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Double Bond Pharmaceutical International AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -48.03%.
As of the last closing price of SEK0.47, shares in Double Bond Pharmaceutical International AB (publ) were trading -20.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Double Bond Pharmaceutical International AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Double Bond Pharmaceutical International AB (publ)'s directors